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Abstract
Background:  Recent clinical trials in Africa, in combination with several observational
epidemiological studies, have provided evidence that male circumcision can reduce HIV female-to-
male transmission risk by 60% or more. However, the public health impact of large-scale male
circumcision programs for HIV prevention is unclear.
Methods: Two mathematical models were examined to explore this issue: a random mixing model
and a compartmental model that distinguishes risk groups associated with sex work. In the
compartmental model, two scenarios were developed, one calculating HIV transmission and
prevalence in a context similar to the country of Botswana, and one similar to Nyanza Province, in
western Kenya.
Results: In both models, male circumcision programs resulted in large and sustained declines in
HIV prevalence over time among both men and women. Men benefited somewhat more than
women, but prevalence among women was also reduced substantially. With 80% male circumcision
uptake, the reductions in prevalence ranged from 45% to 67% in the two "countries", and with 50%
uptake, from 25% to 41%. It would take over a decade for the intervention to reach its full effect.
Conclusion: Large-scale uptake of male circumcision services in African countries with high HIV
prevalence, and where male circumcision is not now routinely practised, could lead to substantial
reductions in HIV transmission and prevalence over time among both men and women.
Background
UNAIDS estimates that 38.6 million people globally are
currently living with HIV, and that in 2005, 4.1 million
new HIV infections occurred [1]. Although the life expect-
ancy of people living with HIV has increased substantially
with the introduction of anti-retroviral therapy (ART), it is
still uncertain whether ART will have a major impact in
reducing the spread of HIV[2]. More than two decades
after the discovery of HIV, the range of public health
measures to control sexual transmission is still limited.
The ideal intervention, of course, would be a highly effec-
tive vaccine that offers long-lasting protection, but as yet
the search for an effective vaccine has proven elusive, and
it is by no means certain that one will become available in
the foreseeable future.
Published: 13 March 2007
BMC Infectious Diseases 2007, 7:16 doi:10.1186/1471-2334-7-16
Received: 15 April 2006
Accepted: 13 March 2007
This article is available from: http://www.biomedcentral.com/1471-2334/7/16
© 2007 Nagelkerke et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Infectious Diseases 2007, 7:16 http://www.biomedcentral.com/1471-2334/7/16
Page 2 of 15
(page number not for citation purposes)
Until recently, the growing evidence for a protective effect
of male circumcision (MC) against HIV infection has
received comparatively little attention from health
authorities, despite a dearth of proven effective alternative
preventive interventions. The first reports that male cir-
cumcision may protect against female-to-male HIV trans-
mission appeared very early during the HIV epidemic[3].
Since then, the evidence for such protection has been
accumulating. Associations have been found both ecolog-
ically and epidemiologically[4-8], and recently also exper-
imentally[9]. In a randomized clinical trial carried out in
the Orange Farm community of South Africa, 20 out of
1545 circumcised men (incidence rate 0.85/100 person
years) became infected, compared to 49 out of 1582 men
in the control group of delayed circumcision (incidence
rate 2.1/100 person years). With an estimated relative risk
of infection of 0.40 when analyzed on an intention-to-
treat basis, MC had a very high protective effect. This pro-
tection changed only marginally to a relative risk of 0.39
when taking into account behavioural factors, including
possible increases in risk taking (behavioural disinhibi-
tion or risk compensation[10]) after circumcision. In fact,
the relative risk estimate was even lower, 0.24, when the
data were analyzed on a per-protocol basis. Similar trials
have been undertaken in Nyanza Province (Kisumu), in
Kenya[11-13] and Rakai, Uganda[14,15]. Although
results have not yet been fully published, the Kenyan and
Ugandan trials were stopped in December 2006, as the
Data Safety and Monitoring Board determined that the
protective effect of MC was sufficiently strong that contin-
ued enrolment was unethical, and it was necessary to offer
circumcision to the control groups [16,17]. In Kenya, it
was found that only 22 of the 1,393 circumcised men
enrolled in the study were infected with HIV, compared to
47 of the 1,391 men who had yet to be circumcised, giving
an estimated protective effect of 53%. In Uganda, 4,996
HIV-negative, uncircumcised men were enrolled, equally
between circumcision and control groups. With 43
infected among the uncircumcised men and 22 among
the circumcised men, it found an almost identical esti-
mated protective effect of 48%. Although the protective
effects of circumcision were slightly less than those found
in the Orange Farm trial, the results of these more recent
trials are clearly consistent with the South African trial,
making the case for a protective effect of MC very strong.
Together they appear to constitute overwhelming evi-
dence that male circumcision can reduce female-to-male
HIV transmission by 45–65% in sub-Saharan Africa.
Another Rakai trial will also analyze the impact of male
circumcision on male-to-female HIV transmission. Some
evidence that MC reduces male-to-female transmission,
especially when the male has low viral load, was provided
by a study in Rakai on discordant couples[18,19].
While the epidemiological evidence and the clinical trials
provide cogent evidence for the impact of MC on HIV
transmission, it is still unclear what the public health
impact would be of male circumcision introduced on a
large scale, and whether it would be sufficiently effective
and cost-effective to justify its introduction as a wide-
spread preventive measure[20]. Unlike prevention efforts
with non-communicable diseases, this impact is by no
means obvious. First, in highly sexually active men, a
lower per-contact risk of transmission may only delay but
not prevent infection, thereby reducing the effect of the
intervention. Second, protecting men from getting
infected may have effects similar to herd immunity. As
preventing men from becoming infected clearly also pro-
tects their subsequent sex partners, the effects of large
scale MC may be larger than expected on the basis of sim-
ply examining female-to-male transmission relative risks.
Third, it is not known how long it would take to observe
a substantial drop in HIV incidence and prevalence, or
how long it would take until a new equilibrium situation
would be reached. Finally, it is not well understood how
MC and other interventions, e.g. female sex worker-
focused preventive interventions, would interact. The
"gold-standard" for answering these questions, and for
assessing the long term effects of large scale introduction
of MC, would be a community randomized trial, i.e. to
randomize entire communities instead of individuals.
Such a trial, however, would be extremely costly and
impractical, requiring large sample sizes and follow-up of
likely over a decade.
There are two alternatives to such a trial. The first is to
resort to ecological data, i.e. comparisons among regions
or countries. Although clearly not randomized, and
potentially subject to ecological fallacy (e.g. confounding
by religious practices, tribal cultural differences, etc.), the
results of the South African trial appear to justify a causal
interpretation of the observed ecological differences in
HIV epidemiology between MC and non-MC regions.
These ecological differences have been well documented,
and were among the first observations suggesting a protec-
tive effect of MC. Typically, countries or regions in Africa,
such as West Africa, but also parts of East Africa (for exam-
ple much of Kenya and Ethiopia) where male MC is
widely practised, appear to have much lower HIV preva-
lence than parts of Africa where MC is rare[4,6], and adult
HIV prevalence rarely exceeds 10%. On the other hand in
non-MC areas, mostly in the zone ranging from the Afri-
can Great Lakes Region to KwaZulu Natal in South Africa,
adult HIV prevalence in many places exceeds 20%.
The second alternative is to use modelling, in which sets
of mathematical equations or (stochastic) computer sim-
ulations are used to mimic the HIV epidemic. To model
the impact of MC on the HIV epidemic, differentBMC Infectious Diseases 2007, 7:16 http://www.biomedcentral.com/1471-2334/7/16
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approaches can be taken. One approach was published
recently[21]. However, it only explores full MC coverage,
i.e. a scenario where all men are circumcised before
becoming sexual active. This level of circumcision cover-
age is unlikely to be achieved by even the best of circum-
cision programs. Also, some men who ultimately accept
MC may delay it until after they become sexually active,
and therefore be at higher risk for some time. Further-
more, while the authors recognize that ignoring heteroge-
neity in sexual activity would lead to a predicted steady
state prevalence of HIV that is much higher than is gener-
ally observed, they incorporated this heterogeneity into
their model only indirectly. Instead of deriving the epide-
miology of HIV from assumed heterogeneity in sexual
behaviour, they postulate an ad-hoc exponential relation-
ship between sexual contact rates and HIV prevalence.
While this may be adequate as a statistical tool to fit
observed South African data, it is unclear whether this is
satisfactory for predicting events under different circum-
stances such as the effects of an MC program in a wide
range of African countries, possibly differing substantially
from South Africa. Here, we will present two other
approaches: 1) a simple mathematical model assuming
random (proportionate) mixing, and postulating explic-
itly assumptions about heterogeneity in sexual behaviour,
to identify what the effect of MC on the epidemiology of
HIV could be under this assumption; and 2) to make
more specific predictions, a compartmental deterministic
model, originally developed to explore the effects of other
HIV interventions, such as vaccines, ART, or sex-worker
focused interventions[22]. We introduced male circumci-
sion into these models and then calculated HIV transmis-
sion over time. We used two different models, instead of
only one, as a reciprocal sensitivity analysis: only findings
consistent between our two models, each of which makes
different simplifying assumption, are probably robust
with respect to model misspecification. Findings made in
only one model would seem to be crucially dependent on
one of the assumptions of that model, and violation of
that assumption may invalidate conclusions.
Methods
We focused on the impact of MC on two aspects of the
HIV epidemic, viz. its basic reproduction number, R0, and
the gender specific HIV prevalence. R0  is the average
number of secondary infections generated by a typical
HIV case in a "naïve" population, i.e. when the infection
has just been introduced. In both the random mixing and
the compartmental model, we used as the baseline rela-
tive risk the intention-to-treat estimate found in the
Orange Farm study, viz. 0.40, corresponding to 60% pro-
tection.
Random mixing model
The simplest, and one of the first and most widely used
mathematical models for the HIV epidemic, because of its
relative mathematical tractability, is the "Anderson-May"
model[23-25]. It assumes random mixing, i.e. individuals
randomly choose from among the number of partner-
ships that are "on offer", at a (per individual) constant
rate ci. The population distribution of this rate can be con-
tinuous (unlike compartmental models), and realistically
has a long "tail", representing the fact that few people
have high, but most people have low, rates of partner
change. Heterosexual contact is assumed, and partners
from the opposite sex are selected proportional to their
(i.e. the partners') rate of partner change. Thus the rate of
forming a partnership between two specific individuals is
proportional to the product of the rate of partnership of
the two individuals. The model further assumes homoge-
neous infectivity during the duration D (Dm in males, Df
in females) of HIV infection, and a fixed risk of transmis-
sion per partnership, viz. βmf, the risk of an infected male
transmitting HIV to an uninfected female partner during
their entire partnership, and similarly βfm, the female-to-
male risk.
Let xi denote either βfmciDm or βmfciDf, the "scaled mixing
rates" of male and female individuals (indexed by i). Let
Nm(x) denote the probability density of the distribution
of x among men, and Nf(x) the same among females. Let
Im(x)dx and If(x)dx denote the proportion of the popula-
tion with scaled mixing rate between x and x+dx and that
is HIV infected (and hence assumed to be infective as
well). Further, let Nm 
1, and Nm 
2 denote for males the
expectation of x and x2 respectively with respect to the dis-
tribution Nm(x), and Nf 
1 and Nf 
2 the same for females. If
all males and all females had the same scaled mixing rate
Nm 
1 and Nf 
1, respectively, then the male and female HIV
prevalence could be simply calculated from the fact that
pre-emption (When the prevalence of HIV is high, infec-
tious individuals often choose partners who are already
infected themselves, and cannot therefore become
infected. This mechanism is called pre-emption [26]) is
the only density dependent mechanism of HIV transmis-
sion. As all men and women would have the same rate of
partner change, the prevalence πm and πf among random
male and female partners would be the same as among
the population as a whole, and we would have
πm = Nm 
1πf(1-πm)
and similarly
πf = Nf 
1πm(1-πf)
yielding both πm and πf as a function of the male and
female scaled mixing rates, viz.BMC Infectious Diseases 2007, 7:16 http://www.biomedcentral.com/1471-2334/7/16
Page 4 of 15
(page number not for citation purposes)
πm = (Nm 
1 Nf 
1 - 1)/{(Nm 
1+1) Nf 
1}
and
πf = (Nm 
1 Nf 
1 - 1)/{(Nf 
1+1) Nm 
1}
Under this homogeneity assumption (which is highly
unrealistic), R0 
2 = 1/{(1-πm)(1-πf)} = Nm 
1 Nf
1, i.e. the
product of the two scaled mixing rates. In reality, of
course, scaled mixing rates are highly heterogeneous and
the infection rate among randomly chosen sex partners is
much higher than among the population as a whole, as
partners are selected proportional to their rate of partner
change. To calculate male and female equilibrium
("static") HIV prevalence under heterogeneity in scaled
mixing rates, for this random mixing model, we proceed
along the lines suggested by Dushoff[27], and extended
the analysis to a two gender population. In equilibrium,
each subgroup with scaled mixing rate x remains constant
in size, i.e. each individual HIV death in a group is
replaced by exactly one new infected individual. The
number of susceptibles in this group is Nm(x)-Im(x). The
probability that any of their sex partners is infected is Λf,
and the rate at which they seroconvert is xΛf/Dm year. Of
those infected, a fraction Im(x)/Dm dies. Thus, the distri-
bution of infected people satisfies, in equilibrium,
Im(x) = xΛf(Nm(x)-Im(x))
Using this notation we find that
R0 
2 = Nm 
2Nf 
2/Nm 
1Nf 
1,
and
and
Similar relations hold for If(x) and Λf.
These equations, which appear analytically intractable for
many scaled mixing rate distributions Nm(x) and Nf(x),
can be solved iteratively as follows. First a value Λf is
assumed and the equation for Im(x) is solved and Λm cal-
culated. This value is then used to solve the equation for
Im(x), and this process is continued until convergence is
reached. We assume that Nm(x) ~Gamma(x, pm, αm), and
similarly Nf(x) ~Gamma(x, pf, αf), because of the long
tailed distribution of the gamma function, reflecting
known characteristics of the distribution of rates of part-
ner change[28]. We used Mathematica® to do the calcula-
tions[29]. Note that this approach solves the problem of
finding a stationary prevalence distribution, not just an
overall stationary prevalence, as was done by Williams et
al  [21]. As male-to-female transmission is generally
believed to be more efficient than female-to-male trans-
mission, Nf 
1 > Nm 
1, or pf/αf > pm/αm. This probably also
holds in places where MC is rare, such as Nyanza prov-
ince, in view of the higher female than male HIV preva-
lences in this province[30]. Interestingly, a recent study on
HIV discordant monogamous couples did not find such a
difference[31], but such couples may not be representa-
tive in terms of important cofactors, for the discordant
relationships where most HIV transmission take place.
Similarly, as female sex workers can have many more sex
partners than any individual heterosexual male, the coef-
ficient of variation in rates of partner change among
women is generally believed to be larger than among
men, giving (1 +1/pf) > (1+1/pm). As the coefficient of var-
iation, 1/vp is probably somewhere between 1 and 3, the
value of p must be approximately between 0.1 and 1[32].
The effects of a transition from 0% MC to 100% MC on
the equilibrium distribution of HIV can be studied by
solving the same equations, but assuming Nm(x)
~Gamma(x, rpm, αm), where r denotes the relative risk of
circumcised men for acquiring HIV infection.
Compartmental model
As some of the assumptions of the above model are ques-
tionable (such as random mixing, a constant rate of
change of partnership for each individual, and a fixed
transmission probability per partnership), we also
explored the effects of male circumcision using a compart-
mental model [33], originally developed to explore the
effects of an HIV vaccine and other interventions on the
HIV epidemic[22,34-36]. An additional advantage of this
approach is that it can also be used to show the expected
time of transition between the current HIV prevalence and
the establishment of a new lower equilibrium prevalence.
Model structure
This compartmental model does not make the assump-
tion of random mixing, but subdivides the population
according to different dimensions (gender, involvement
in commercial sex, circumcision status, HIV infection sta-
tus and stage of infection), into discrete high-risk (male
clients and female sex workers for the high-risk groups)
and low-risk (general population, not involved in paid
sex) groups. Each of these groups is again subdivided into
compartments of individuals who are either HIV -infected
or not, and, for males, whether they are circumcised or
Ix
xNx
x
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fm
f ()
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Λ
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xI x dx
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not. In addition, HIV infection is split into two compart-
ments, early and late, to incorporate non-exponential pro-
gression to AIDS and mortality. Altogether 6
compartments for (living) women and 8 for (living) men
are distinguished. A graph of the model structure is shown
in Figure 1.
For women these 6 compartments are:
1. F11. HIV negative low risk women, not involved in sex
work.
2. F12. Women not involved in sex work, during the early
stages of HIV infection.
3. F13. Women not involved in sex work, during late(r)
stage HIV infection.
4. F21. HIV negative female sex workers.
5. F22. Female sex workers during the early stages of HIV
infection.
6. F23. Female sex workers during late(r) stage HIV infec-
tion.
For men these 8 compartments are:
1. M11. Men who are not sex worker clients, HIV unin-
fected, uncircumcised.
Structure of the compartmental model Figure 1
Structure of the compartmental model. Boxes represent compartments, i.e. the states males or females can be in. Arrows rep-
resent flows of individuals between compartments. High risk groups are male clients of sex workers, and female sex workers 
(csw). Disease progression is subdivided into 2 stages: early and late, including AIDS. Individuals (men) move to the circumcised 
boxes after circumcision. The flow diagram for women is similar except that there exists no circumcised compartment. Sym-
bols refer to compartments and flows formally defined in the Additional file 1 (Compartments: M = male, F = female; first sub-
script: 1 = low risk group, 2 = high risk group; second subscript: 1 = uninfected, 2 = early HIV, 3 = late HIV, 4 =circumcised and 
uninfected. Flows: a = from low risk to high risk group, b = from high risk to low risk group, c = circumcision, i = infection, p = 
progression (to late stage HIV infection), q = death)BMC Infectious Diseases 2007, 7:16 http://www.biomedcentral.com/1471-2334/7/16
Page 6 of 15
(page number not for citation purposes)
2. M14. Men who are not sex worker clients, HIV unin-
fected, circumcised.
3. M12. Men who are not sex worker clients, during the
early stages of HIV infection, either circumcised or not.
4. M13. Men who are not sex worker clients, during late(r)
stage HIV infection, either circumcised or not.
5. M21. Male sex worker clients, HIV uninfected, uncir-
cumcised.
6. M24. Male sex worker clients, HIV uninfected, circum-
cised.
7. M22. Male sex worker clients, during the early stages of
HIV infection, either circumcised or not.
8. M23. Male sex worker clients, during late(r) stage HIV
infection, either circumcised or not.
No age-structure is incorporated, essentially because relia-
ble quantitative information on age-specific assortative
mixing in Africa is not available. However, there is strong
empirical evidence that age-mixing in Sub-Saharan Africa
is substantial and the HIV epidemic sufficiently "leaky" to
expect that ignoring age-specific assortative mixing will
not grossly distort what might be expected in reality
[37,38]. Interactions, i.e. sexual relationships with the
opposite sex, depend on the compartment (high-risk or
low-risk) that individuals are in. For example, "non-cli-
ent" men do not visit sex workers at all. HIV transmission
between low risk population groups consists of two types,
namely through entering into a new marriage-like or
other stable relationship (marriages, regular partners, not
necessarily monogamous), or through "leakage" from
infected individuals, which involves both all non-paid
casual sex and all existing sexual relationships at the time
an individual becomes HIV infected. The risk of transmis-
sion to initially HIV negative partners in new marriage-
like relationships is assumed to be determined by the
product of the parameters marrate_male ("marriage-rate"
of men) and stabfactor (a multiple of the per-contact trans-
mission rate with a sex worker). Instead of making this
product one parameter, we used two parameters in order
to make sure that the number of such stable relationships
is the same for men and for women. This was achieved by
making the annual rate of entering into a new stable rela-
tionship a (fixed) parameter for men, but "demand
driven" for women. The annual transmission through
"leakage" is set by an independent parameter (leak) that
sets the level of leakage when all partners would be ini-
tially HIV uninfected. However, the amount of leakage
decreases when HIV prevalence increases due to "pre-
emption" (i.e. some partners cannot be infected as they
are already HIV seropositive). The relative risk of male-to-
female leakage and female-to-male leakage is assumed to
be the same as that for male-to-female and female-to-
male transmission probability per high risk (FSW-client)
contact. The only mode of HIV transmission is assumed to
be heterosexual. The co-factor effects of sexually transmit-
ted infections are not explicitly modelled, but are
assumed to affect the average risk of sexual transmission,
as they did in the studies on which transmission parame-
ter values were based. Demand for sex work, i.e. the rate
of becoming a sex-worker client, and the frequency of
intercourse with sex-workers is assumed to be an inde-
pendent mechanism, but the rate of becoming a sex
worker and also the average number of client contacts per
sex worker are demand driven. Specifically, the rate of
becoming a sex worker is assumed to depend exponen-
tially on the per sex worker annual number of contacts
with clients. Since group membership (e.g. being a sex
worker) of individuals is not fixed, but may change over
time (e.g. women may practice sex work for a few years
only), individuals may move between high risk and low
risk compartments. Transitions between compartments
(groups) are given by differential equations, which are
solved numerically using ModelMaker® (version 3)[39].
The model compartments, flows, variables and parame-
ters are formally described in the Additional file 1.
Choice of parameter values
We adjusted the parameters of the model to incorporate
recent (higher) estimates of female-to-male HIV transmis-
sion risk (fm_risk) per high-risk contact among uncircum-
cised high-risk men[40], and to obtain a reasonable fit to
prevalence estimates in two regions in Africa where MC is
uncommon (approximately 10% of all adult males) and
HIV prevalence is high,viz. Nyanza Province in Kenya, and
Botswana in southern Africa. Recent HIV prevalence esti-
mates[1] of Botswana for the entire 15–49 years old pop-
ulation are somewhat lower than earlier ones based on
ANC surveillance which we used for our study so that our
model perhaps does not adequately reflect the whole of
Botswana and may at best represent the worst affected
areas of this country. The major difference between the
two sites was that the number of non-commercial casual
contacts was assumed to be higher in the "Botswana" sce-
nario than in the "Nyanza" scenario, by choosing a higher
value of leak. Other parameters were either chosen on the
basis of published data or plausible information, or were
"tweaked" (tuned) to provide the desired baseline preva-
lences[35].
Specifically, the parameters cust and uncust representing
the annual rates by which men become clients of sex
workers and the rate of moving back to low risk were
based on "estimates" that approximately 20% of men are
clients of sex workers at any given time[41,42]. TheBMC Infectious Diseases 2007, 7:16 http://www.biomedcentral.com/1471-2334/7/16
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parameters controlling the rates of becoming a sex-worker
and moving back to the low risk groups were based on the
assumption that slightly less than 10% of women at any
time exchange sex for money[43], in combination with
the assumption that women tend to remain sex-worker for
only a few years. The contact rate between clients and sex
workers of once every two weeks was suggested inter alia
by a report of 11 such contacts during 12 man-weeks in a
probably biased sample of male clients in Uganda[44],
and a study reporting clients visiting sex-workers in
Nyanza, Kenya once or twice weekly [45]. As the latter
study also reported that most clients were not consistently
using condoms with sex workers we chose the baseline
level of unprotected sex unprot due to no condom use or
incorrect use to be 80%. The parameters hivprog, and
mu_aids were based on the assumption of an 8 years dura-
tion from infection to AIDS death and an arbitrary 50:50
division into early and a late stage infection. Parameters
mu_pos and mu_neg of 0.028 and 0.026 respectively, were
chosen on the basis of a duration of 35–40 years between
entering the sexually active population and leaving this
population due to ageing or death and the assumption of
marginally higher mortality rates among early HIV posi-
tive individuals. The parameters malegr and femgr of 0.04
were chosen to obtain realistic population growth rates.
These parameters determine the influx into the male (at
annual rate malegr* population) and female (at annual
rate femgr* population) adult sexually active population
due to the ageing of children. The ratio of male-to-female
(mf_risk) and female-to-male (fm_risk) risk was chosen on
the basis of observed prevalence ratios. The parameters
marrate_male,  stabfactor, and leak  were tuned to yield
desired baseline prevalences. However, it may be note-
worthy that there is some arbitrariness in the choice of
these parameter values, as it appeared that the two non
sex-worker transmission mechanisms were largely inter-
changeable.
On the basis of the Orange farm trial, we assumed a rela-
tive risk of MC for female-to-male transmission of 0.4. We
further assumed absence of behavioural disinhibition
(risk compensation, i.e. increased risk taking) after cir-
cumcision, and no effect of male circumcision on male-
to-female transmission
In our model specification, men were not circumcised
instantaneously, but uncircumcised men were recruited as
a constant rate leading to a specified (50% or 80%) equi-
librium prevalence of circumcision among HIV unin-
fected men. As initially most men are uncircumcised, the
number of men getting circumcised is higher initially than
in equilibrium when circumcision numbers are just high
enough to maintain equilibrium circumcision levels.
Sensitivity analyses
For our main (baseline) model specifications, we
assumed a relative risk of MC for female- to-male trans-
mission of 0.4, no behavioural disinhibition (risk com-
pensation), and no effect on male-to-female
transmission. These three assumptions were subjected to
sensitivity analyses as follows:
1) As a first sensitivity analysis we considered two
"extreme" relative risks of the effect of circumcision on
female-to-male transmission, viz. a RR of 0.25, and a RR
of 0.6 for female-to-male transmission. These values cor-
respond roughly to the per-protocol estimate of the RR
from the Orange Farm trial, and the upper limit of the
90% CI of the RR, respectively, and thereby constitute
moderately optimistic and pessimistic estimates. The high
RR value of 0.6 also somewhat exceeds the estimated
effects in Uganda and Kenya and thus seems to be a "safe"
upper limit of the RR.
2) As a second sensitivity analysis we explored the effect of
a (moderate) protective effect of MC on male-to-female
transmission, which we had assumed absent in our main
analysis. Instead of a relative risk of 1 for MC (i.e. no effect
on male-to-female transmission), we assumed a relative
risk of 0.75.
3) As indicated above, the unadjusted and adjusted (for
behavioural variables) protection levels (i.e. 1-RR) esti-
mates obtained from the Orange Farm trial were very close
(0.60 and 0.61 respectively). It thus appears that in this
trial, negative behaviour change (disinhibition or risk
compensation) following circumcision, leading to higher
risk taking, was not an important effect. However, this
may be partly due to the intensive counselling that trial
subjects received, and in practice, after program scale-up,
some degree of disinhibition would seem plausible. As a
third sensitivity analysis, we therefore considered the pos-
sibility that circumcised men would abandon condom use
in high-risk sexual contacts (assumed to be 20% effec-
tively initially).
4) As a fourth sensitivity analysis, we explored the impact
of changing the assumption of uniform infectiousness
(with the underlying idea that most infections take place
both early and  late during infection), to one in which
individuals are more (on average 5 times more) infectious
during the first year after infection than during the
remainder of their infection. This should also provide a
reasonable approximation to the situation in which infec-
tiousness is extremely high for only a few weeks, either
due to high viraemia during primary infection [46] or due
to the effect of a concomitant sexually transmitted infec-
tion that increases both HIV susceptibility and infectious-
ness.BMC Infectious Diseases 2007, 7:16 http://www.biomedcentral.com/1471-2334/7/16
Page 8 of 15
(page number not for citation purposes)
5) As a fifth and final sensitivity analysis, we explored sev-
eral different other "realistic" mixes of sexual behaviour
parameters (client-CSW contacts, other casual contacts,
and new stable partnerships) that were consistent with the
same assumed male and female baseline HIV prevalences.
Results
Random mixing model
Three scenarios with different degrees of heterogeneity in
rates of partner change were considered. In all three sce-
narios, it was assumed that per-partnership male-to-
female transmission was 2.5 times more efficient than
female-to-(uncircumcised) male transmission, and that
MC has a 60% protective effect.
Figure 2, bottom panel, shows the effect of MC on the
equilibrium HIV prevalence when all individuals have
identical contact rates, i.e. a homogeneous population.
HIV prevalence levels vary considerably with the basic
reproductive rate. In populations where male circumci-
sion is not practised, HIV prevalence is zero when R0 ≤ 1,
and rises to about 85% among women and 60% among
men at levels of R0 of 4–5. In populations where male cir-
cumcision is practised, HIV prevalence is zero when (the
non-MC) R0 equals 1.5, and rises to about 80% among
women and 45% among men at levels of (non-MC) R0 of
4–5. For realistic levels of HIV prevalence, R0 would be
between 1 and 2. For example, for "Botswana", R0 would
only be about 1.5, making it possible to completely elim-
inate the infection from the population.
Figure 2, middle panel, shows the effect of male circumci-
sion on the equilibrium male and female HIV preva-
lences, when the parameters for heterogeneity, pm and pf,
are set to 1 and 0.5. In populations where male circumci-
sion is not practised, HIV prevalence is about 40% for
females and 30% for males (similar to "Botswana"), at an
R0 of 4. MC would reduce this prevalence to about 25–
30% for females and 15% for males.
Figure 2, top panel, shows these curves for values of pm
and pf set to 0.5 and 0.25. In populations where male cir-
cumcision is not practised, HIV equilibrium prevalence is
about 30% for females and 25% for males at levels of R0
of 4–5. MC would reduce this prevalence to about 25%
for females and 12% for males. The value of R0 in "Bot-
swana" would exceed 6, making it extremely difficult to
eliminate the infection from the population.
Compartmental Model
Figures 3 and 4 show the relationship between HIV prev-
alence and calendar time. The model was run for the
period 1950–2100. Male circumcision was introduced in
the year 2010. The first 50 years (1950–1999) were used
as a "burn in", using all of the demographic and transmis-
sion parameters (but without MC) described above, in
order to reach approximate pre-circumcision equilibrium
HIV prevalence levels associated with these parameters.
Note that this is not assumed to adequately represent the
pre-2000 HIV epidemic; if only because HIV was probably
introduced some time during the 1970s. After introduc-
tion of MC, it takes several decades to reach the new equi-
librium associated with the lower transmission risks. It
even takes somewhat longer than a decade to reach half
the ultimate impact. In part this is because prevalent cases
are removed only slowly by mortality. However, part of
this is also due to the assumption that not all men are cir-
cumcised instantaneously, but rather, more realistically,
that uncircumcised men are recruited at a fixed rate, and
the pool of uncircumcised men diminishes only gradu-
ally.
Figures 3, 4 also show the equilibrium (i.e. in the year
2100) male and female HIV prevalence under the first
three sensitivity analysis assumptions.
High (80%) MC uptake
Figure 3, lower panel, shows the effects of the introduc-
tion of MC in "Botswana" for a program that manages to
increase MC from 10% to 80% of susceptible (HIV nega-
tive) males over a period of about 10 years. Female HIV
prevalence decreased over time from slightly over 40% to
about 20%. Male HIV prevalence decreased from about
30% to slightly over 10%. Figure 4, lower panel, shows the
same effects for "Nyanza Province" with 80% MC uptake
over 10 years. Female HIV prevalence decreased over time
from 22% to about 10%. Male HIV prevalence decreased
from about 17% to 7%.
Low (50%) MC uptake
Figure 3, top panel, shows the effects of MC in "Botswana"
for a program that achieves a male circumcision rate of
only 50%, also over about a 10 year period. Female HIV
prevalence decreased over time from slightly over 40% to
about 30% Male HIV prevalence decreased from about
30% to 20%. Figure 4, top panel, shows the same scenario
as Figure 3, top panel, but for "Nyanza Province". Female
HIV prevalence decreased over time from 22% to about
15%. Male HIV prevalence decreased from about 17% to
slightly over 10%.
Sensitivity Analyses
The first three sensitivity analyses clearly show (Figures 3,
4) that the impact of MC is very sensitive to assumptions
about the degree of protection (relative risk) afforded by
male circumcision, especially in terms of female-to-male
transmission. However, if MC also reduces the efficiency
of male-to-female HIV transmission, then there could be
a substantial further impact on equilibrium HIV preva-
lence, among both men and women. Behavioural disinhi-BMC Infectious Diseases 2007, 7:16 http://www.biomedcentral.com/1471-2334/7/16
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bition (risk compensation) had a much smaller impact,
perhaps because the potential for disinhibition was
assumed to be small (reduction of condom use in contacts
with sex workers from 20% to 0%; no effect on transmis-
sion in other partnerships).
The fourth sensitivity analysis (non-homogeneous infec-
tiousness) did not substantially affect the ultimate equi-
librium HIV prevalence (for the same pre-intervention
equilibrium levels), but somewhat accelerated the rate of
approximation to the new equilibrium, especially during
the early phase of the introduction of the intervention. All
parameter combinations tried under the fifth sensitivity
analysis (varying sexual mixing parameters) yielded very
similar effects of MC on HIV prevalence over time (not
shown).
Discussion
There are different approaches to estimating the potential
impact of male circumcision on the HIV epidemic. As
The relationship between R0, male circumcision (MC), and sex-specific equilibrium HIV prevalence, under a random mixing  assumption, assuming different levels of heterogeneity of sexual behaviour (rates of partner change) Figure 2
The relationship between R0, male circumcision (MC), and sex-specific equilibrium HIV prevalence, under a random mixing 
assumption, assuming different levels of heterogeneity of sexual behaviour (rates of partner change). The distribution of male 
and female rates of partner change (x) are assumed to be Nm(x) ~Gamma(x, pm, αm) and Nf(x) ~Gamma(x, pf, αf) respectively. 
Bottom panel: homogeneous rates of partner change; middle panel: moderate heterogeneity in rates of partner change with 
parameters pm = 1 & pf = 0.5; top panel: high heterogeneity in rates of partner change with parameters pm = 0.5 & pf = 0.25. 
Continuous arrows indicate the approximate position of "Botswana" and the dotted arrow indicates the approximate position 
of "Nyanza".BMC Infectious Diseases 2007, 7:16 http://www.biomedcentral.com/1471-2334/7/16
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noted above, the simplest one compares regions in Africa
where MC is universally practised with regions where it is
exceptional. This approach has the drawback that these
regions were not randomly allocated to MC or not, and
that confounding is a real possibility. In addition, both
within MC areas and within non-MC areas, there are sub-
stantial heterogeneities in HIV prevalence which are not
well understood[47]. An advantage of this ecological
approach, however, is that it does not depend on esti-
mates of the effect of MC, and it automatically includes
any effect of MC not taken into account in the model,
such as a possible higher protection afforded by MC for
the most sexually active men, or an effect on male-to-
female transmission.
The impact of male circumcision (MC) on HIV prevalence in the Botswana setting, according to our compartmental model,  with high, 80%, MC uptake (bottom panel) and moderate, 50%, MC uptake (top panel) Figure 3
The impact of male circumcision (MC) on HIV prevalence in the Botswana setting, according to our compartmental model, 
with high, 80%, MC uptake (bottom panel) and moderate, 50%, MC uptake (top panel). Predictions are for the period 2000–
2100, when male circumcision is introduced in 2010. In addition the figure shows the results of 4 different sensitivity analyses: 
RR0.25: if protection afforded by circumcision would be as high 75% (RR 0.25); RR0.60: if it would be as low as 40% (RR 0.60); 
DISINHIB: if it would lead to disinhibition in the sense that condom use in high risk sex would be abandoned; MF 0.75: if male 
circumcision would reduce the risk of male-to-female transmission by 25%.BMC Infectious Diseases 2007, 7:16 http://www.biomedcentral.com/1471-2334/7/16
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The other approach to exploring the effects of MC is math-
ematical modelling. While the techniques for modelling
complex epidemics of infectious diseases are well devel-
oped, modelling the HIV epidemic is plagued by substan-
tial uncertainty around the estimates for most key
parameters, such as per-contact or per-partnership trans-
mission risks, or the effects of co-factors on these risks. In
addition, sexual networks in Africa, as elsewhere, are
poorly understood, and the methodology for studying
them, such as sexual behaviour surveys, is still unrelia-
ble[48,49]. Fitting models to observed data to estimate
parameters is not an entirely satisfactory solution, as the
number of unknown parameters involved in any realistic
model usually exceeds the available data, which also tend
to be selective and scarce. Even the actual HIV prevalence
in many countries, including Botswana, is a moot
issue[50]. The amount of heterogeneity in sexual contact
rates is an essential parameter governing the effect of MC
The impact of male circumcision (MC) on HIV prevalence in the Nyanza setting, according to our compartmental model, with  high, 80%, MC uptake (bottom panel) and moderate, 50%, MC uptake (top panel) Figure 4
The impact of male circumcision (MC) on HIV prevalence in the Nyanza setting, according to our compartmental model, with 
high, 80%, MC uptake (bottom panel) and moderate, 50%, MC uptake (top panel). Predictions are for the period 2000–2100, 
when male circumcision is introduced in 2010. In addition the figure shows the results of 4 different sensitivity analyses:RR0.25: 
if protection afforded by circumcision would be as high 75% (RR 0.25); RR0.60: if it would be as low as 40% (RR 0.60); DISIN-
HIB: if it would lead to disinhibition in the sense that condom use in high risk sex would be abandoned; MF 0.75: if male circum-
cision would reduce the risk of male-to-female transmission by 25%.BMC Infectious Diseases 2007, 7:16 http://www.biomedcentral.com/1471-2334/7/16
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for given equilibrium HIV prevalences. For low rates of
heterogeneity, prevalence rates as commonly observed in
Africa would correspond to rather low basic reproductive
numbers, R0, and in such contexts, MC could well be able
to eliminate HIV altogether. Clearly, however, this would
be unrealistic, as sexual behaviour is highly heterogene-
ous, and we know that some countries where MC is prac-
tised universally still have significant HIV transmission,
albeit not as great as in countries where MC is rare. Values
of R0 in Africa are not well known. They can be estimated
from the intrinsic doubling time of the epidemic, e.g.
slightly over 1 year in South Africa[51], giving rise to a
very high R0 estimate of approximately 7. However, this
estimate is based on the assumption that the number of
secondary infections generated by an individual infected
with HIV would be constant over the whole period
between infection and death. As most secondary infec-
tions are probably generated during the early phases of
infection, the true value of R0 should be much lower.
To partly overcome model uncertainties, and to explore
the sensitivity of findings to specific model choices
(model sensitivity), we attempted to estimate and com-
pare the impact of MC on the HIV epidemic using two dif-
ferent modelling approaches, and to identify where
predictions agree and where they do not. Both approaches
indicate a substantial impact of MC on both male and, to
a lesser extent, female HIV prevalence. The random mix-
ing model, when assuming a gamma distributed rate of
partner change, suggested decreases in male prevalence of
at least 40%, but for realistic prevalences perhaps appreci-
ably higher, with approximately a 60% reduction in prev-
alence among men and 30% among women. These
estimates are similar to those predicted using our com-
partmental model, although the assumptions for these
models were different, with an increase in MC rates from
10% to 50% or 80% in the latter model as opposed to
from 0 to 100% in the former. This similarity suggests that
our compartmental model in which individuals can move
between high-risk and low risk compartments at signifi-
cant rates can be closely approximated by a random mix-
ing model. Our results also agree with those of Williams
et al [21], although we predict a somewhat stronger effect
of MC than they do. For example, for Botswana, they pre-
dict a reduction in incidence of 1.17%/year. Taking into
account the average duration of HIV disease, between HIV
infection and death, this corresponds to a decrease in
prevalence of approximately 10% from 37.3% to approx-
imately 27%, i.e. a relative reduction of 25–30%. The
somewhat stronger effect predicted from our models
appears to be due to a different approach to handling het-
erogeneity in sexual behaviour.
Results from our compartmental model indicate that,
although the declines in HIV prevalence after male cir-
cumcision programs are expanded are substantial, it may
take some time to reach the new equilibrium prevalences,
particularly as it may take time to reach high coverage
with male circumcision services. Even with a vigorous pro-
gram, it may take as much as two decades to reach equi-
librium associated with the protection afforded by MC.
Nevertheless, within a few years, a decline in prevalence
should set in and the burden of HIV should diminish rap-
idly, with the incidence naturally declining faster than the
prevalence. An interesting finding is the generally concave
shape of the relationship between R0 and prevalence. The
implication of this shape is that MC may have a positive
synergy with other interventions that reduce R0 by a fixed
amount. Interventions that reduce R0 by a fixed percent-
age (perhaps a more probable scenario) do not have this
advantage. Plots (not shown) of the prevalence, as pre-
dicted by the random mixing model, against the loga-
rithm of R0, show approximately linear relationships,
suggesting that the absolute decline in prevalence contrib-
uted by additional interventions would be approximately
constant. Of course, the relative  decline of additional
interventions would increase after the introduction of
MC. Thus, MC would likely have positive synergistic inter-
actions with other interventions, such as sex worker pre-
ventive interventions.
Our findings appear to be relatively insensitive to behav-
ioural disinhibition (risk compensation), perhaps
because it was assumed that the potential for disinhibi-
tion was small, given that most sex worker clients (at least
in Nyanza province [45]) do not use condoms consist-
ently in the baseline scenario. Naturally, our results were
quite sensitive to the assumed level of protection (relative
risk) afforded by male circumcision, both on female-to-
male and male-to-female transmission. As ongoing MC
trials have been stopped and other trials are unlikely to be
carried out in the future, estimates of the protection
afforded by MC are likely to remain somewhat imprecise.
As our models lack an age structure, one important aspect
of a general MC intervention that is not addressed by our
models is the effect of the intervention on the average age
of infection, and consequently the development of AIDS
and death. When the force-of-infection declines, the aver-
age age of infection increases, and consequently the
number of life-years lost, for every incident HIV infection,
also decreases. Precise estimation of this effect would
require detailed knowledge of age-specific sexual behav-
iour patterns. However, it is clear that in terms of the
number of life-years lost, the effect of MC on the HIV epi-
demic may be larger than that measured solely in terms of
HIV prevalence, and the cost-effectiveness of MC interven-
tions would thus be enhanced. Rough estimates of the
gains in life expectancy that large scale MC programs may
yield can be gleaned from estimates of decreases in life-BMC Infectious Diseases 2007, 7:16 http://www.biomedcentral.com/1471-2334/7/16
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expectancy attributable to AIDS[26]. For example, in Zim-
babwe, it is estimated that AIDS has reduced life expect-
ancy by 22.2 years. Let us assume that, in equilibrium,
approximately 2%, i.e. roughly half the gross birth rate (as
only males will be circumcised) in many parts of Africa,
will be eligible for circumcision, at a cost of US$20 –
US$40 per procedure, depending on country, method of
implementation, etc. Then the per capita cost of maintain-
ing a circumcision programme will be approximately 2%
of the cost of a male circumcision, i.e. US$ 0.40 – US$
0.80. The benefits of such a MC program would be a
reduction in the loss in life expectancy due to AIDS by 20–
50%; i.e., regaining 5–11 years of life expectancy. Alterna-
tively, it amounts to reducing an incidence rate of approx-
imately 1% per capita (the whole population, not only
adults) by 20–50%. At less than a dollar per capita annu-
ally, this would translate into a cost of approximately
100–500 US$ per HIV infection averted. Similar cost esti-
mates ($117-$306) were calculated by Kahn et al for Gau-
teng, South Africa[52]. This would make the cost-
effectiveness of MC comparable to or better than other
accepted cost-effective interventions, such as anti-retrovi-
ral treatment for prevention of mother-to-child HIV trans-
mission[53].
We have not addressed the issue of optimal targeting of
MC programs, but rather assumed either universal circum-
cision or random uptake of circumcision. It may be most
efficient to focus circumcision services on high-risk men,
but these men may not be easy to identify. Alternatively,
circumcising successive cohorts of young men just prior to
onset of sexual debut (e.g. 12–16 year-olds) may be highly
efficient. Fortunately, this is the age range of most circum-
cisions occurring traditionally in eastern and southern
Africa. Actual MC service delivery programs will likely
depend more on factors such as cultural preferences and
country-specific infrastructure than on mathematically
optimal service and resource allocation. Similarly, nega-
tive effects of large scale circumcision such as adverse
effects of surgery, will also depend on specific delivery
programs. These should be assessed, preferably in realistic
pilot projects, and taken into account in program specific
effectiveness and cost-effectiveness analyses, before trial
projects are scaled-up.
Conclusion
Large-scale uptake of male circumcision services in African
countries with high HIV prevalence and where male cir-
cumcision is not now routinely practised, could lead to
substantial reductions in HIV transmission and preva-
lence over time among both men and women. The full
impact of MC on HIV-related illness and death will only
be apparent after more than a decade. Our findings sup-
port qualitatively similar findings by other authors using
different models [21]. Together with those findings, our
results indicate the approximate range of reduction in HIV
prevalence that would result from large scale introduction
of male circumcision programmes in Africa.
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